120 related articles for article (PubMed ID: 12556092)
1. Prognostic significance of apoptotic index and bcl-2 and p53 expression in epithelial ovarian carcinoma.
Berker B; Dunder I; Ensari A; Cengiz SD; Simsek E
Eur J Gynaecol Oncol; 2002; 23(6):505-10. PubMed ID: 12556092
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer.
Baekelandt M; Kristensen GB; Nesland JM; Tropé CG; Holm R
J Clin Oncol; 1999 Jul; 17(7):2061. PubMed ID: 10561259
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of p53 accumulation in epithelial ovarian carcinomas.
Berker B; Dunder I; Ensari A; Cengiz SD
Arch Gynecol Obstet; 2002 Aug; 266(4):205-9. PubMed ID: 12192480
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of the immunohistochemical expression of p53, bcl-2, c-erb B-2 and cathepsin-D in ovarian cancer patients receiving platinum with cyclophosphamide or paclitaxel chemotherapy.
Protopapas A; Diakomanolis E; Bamias A; Milingos S; Markaki S; Papadimitriou C; Dimopoulos AM; Michalas S
Eur J Gynaecol Oncol; 2004; 25(2):225-9. PubMed ID: 15032288
[TBL] [Abstract][Full Text] [Related]
5. The prognostic importance of p53, bcl-2, and bax in early stage epithelial ovarian carcinoma treated with adjuvant chemotherapy.
Skirnisdóttir I; Seidal T; Gerdin E; Sorbe B
Int J Gynecol Cancer; 2002; 12(3):265-76. PubMed ID: 12060448
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis in epithelial ovarian tumours Prognostic significance of clinical and histopathologic factors and its association with the immunohistochemical expression of apoptotic regulatory proteins (p53, bcl-2 and bax).
de la Torre FJ; García A; Gil-Moreno A; Planaguma J; Reventos J; Ramón y Cajal S; Xercavins J
Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):121-8. PubMed ID: 16876311
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of apoptosis in breast cancer (pT1-pT2). A TUNEL, p53, bcl-2, bag-1 and Bax immunohistochemical study.
Sirvent JJ; Aguilar MC; Olona M; Pelegrí A; Blázquez S; Gutiérrez C
Histol Histopathol; 2004 Jul; 19(3):759-70. PubMed ID: 15168338
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue.
Xie X; Clausen OP; De Angelis P; Boysen M
Cancer; 1999 Sep; 86(6):913-20. PubMed ID: 10491515
[TBL] [Abstract][Full Text] [Related]
9. P53 and Bcl-2 as prognostic predictors in epithelial ovarian cancer.
Sagarra RA; Andrade LA; Martinez EZ; Pinto GA; Syrjänen KJ; Derchain SF
Int J Gynecol Cancer; 2002; 12(6):720-7. PubMed ID: 12445249
[TBL] [Abstract][Full Text] [Related]
10. p53 and related proteins in epithelial ovarian cancer.
Sengupta PS; McGown AT; Bajaj V; Blackhall F; Swindell R; Bromley M; Shanks JH; Ward T; Buckley CH; Reynolds K; Slade RJ; Jayson GC
Eur J Cancer; 2000 Dec; 36(18):2317-28. PubMed ID: 11094305
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma.
Jäckel MC; Sellmann L; Dorudian MA; Youssef S; Füzesi L
Laryngoscope; 2000 Aug; 110(8):1339-45. PubMed ID: 10942137
[TBL] [Abstract][Full Text] [Related]
12. Apoptotic index correlates to bcl-2 and p53 protein expression, histological grade and prognosis in invasive breast cancers.
Zhang GJ; Kimijima I; Abe R; Watanabe T; Kanno M; Hara K; Tsuchiya A
Anticancer Res; 1998; 18(3B):1989-98. PubMed ID: 9677455
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates.
Nakopoulou L; Vourlakou C; Zervas A; Tzonou A; Gakiopoulou H; Dimopoulos MA
Hum Pathol; 1998 Feb; 29(2):146-54. PubMed ID: 9490274
[TBL] [Abstract][Full Text] [Related]
14. Clinical factors and biomarkers which affect a new universal grading system for ovarian epithelial carcinoma.
Ishioka S; Sagae S; Sugimura M; Nishioka Y; Kobayashi K; Kudo R
J Obstet Gynaecol Res; 2001 Dec; 27(6):313-8. PubMed ID: 11794816
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance.
Baretton GB; Diebold J; Christoforis G; Vogt M; Müller C; Dopfer K; Schneiderbanger K; Schmidt M; Löhrs U
Cancer; 1996 Jan; 77(2):255-64. PubMed ID: 8625232
[TBL] [Abstract][Full Text] [Related]
16. An immunohistochemical comparison of P53 and Bcl-2 as apoptotic and MIB1 as proliferative markers in low-grade and high-grade ovarian serous carcinomas.
Mishra SK; Crasta JA
Int J Gynecol Cancer; 2010 May; 20(4):537-41. PubMed ID: 20442586
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of apoptosis and apoptosis-associated proteins in salivary gland adenoid cystic carcinoma.
Jia L; Esguerra RL; Tang X; Yin H; Sakamoto K; Okada N; Takagi M
Pathol Int; 2004 Apr; 54(4):217-23. PubMed ID: 15028021
[TBL] [Abstract][Full Text] [Related]
18. Expression of apoptosis-related markers and HER-2/neu in thymic epithelial tumours.
Pan CC; Chen PC; Wang LS; Lee JY; Chiang H
Histopathology; 2003 Aug; 43(2):165-72. PubMed ID: 12877732
[TBL] [Abstract][Full Text] [Related]
19. The interactive effect of Ras, HER2, P53 and Bcl-2 expression in predicting the survival of non-small cell lung cancer patients.
Kim YC; Park KO; Kern JA; Park CS; Lim SC; Jang AS; Yang JB
Lung Cancer; 1998 Dec; 22(3):181-90. PubMed ID: 10048471
[TBL] [Abstract][Full Text] [Related]
20. bcl-2 expression, p53 accumulation, and apoptosis in ovarian carcinomas.
Diebold J; Baretton G; Felchner M; Meier W; Dopfer K; Schmidt M; Löhrs U
Am J Clin Pathol; 1996 Mar; 105(3):341-9. PubMed ID: 8602616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]